Table 2.
Baseline characteristics of participants by hyperuricemia status
| Character | Total group n = 4855 |
Hyperuricemic | p | |
|---|---|---|---|---|
| NO n = 3918 (80.7) |
YES n = 937 (19.3) |
|||
| Age, n (%) | < 0.01 | |||
| 18–40 years | 1024 (21.1) | 766 (74.8) | 258 (25.2) | |
| 40–65 years | 1879 (38.7) | 1529 (81.4) | 350 (18.6) | |
| ≥ 65 years | 1952 (40.2) | 1623 (83.1) | 329 (16.9) | |
| Gender, n (%) | < 0.01 | |||
| Men | 2019 (41.6) | 1574 (78.0) | 445 (22.0) | |
| Woman | 2836 (58.4) | 2344 (82.7) | 492 (17.3) | |
| Residence, n (%) | < 0.01 | |||
| Urban | 1869 (38.5) | 1415 (75.7) | 454 (24.3) | |
| Rural | 2986 (61.5) | 2503 (83.8) | 483 (16.2) | |
| Education, n (%) | ||||
| Low | 2271 (46.8) | 1910 (84.1) | 361 (15.9) | < 0.01 |
| Middle | 2078 (42.8) | 1633 (78.6) | 375 (21.4) | |
| High | 506 (10.4) | 375 (74.1) | 131 (25.9) | |
| Current smoker, n (%) | 0.46 | |||
| Yes | 966 (19.9) | 778 (80.5) | 188 (19.5) | |
| No | 3889 (80.1) | 3140 (80.7) | 749 (19.3) | |
| Recent drink, n (%) | ||||
| Yes | 840 (17.3) | 623 (74.2) | 217 (25.8) | < 0.01 |
| No | 4015 (82.7) | 3295 (82.1) | 720 (17.9) | |
| BMI ≥ 24.0, n (%) | < 0.01 | |||
| Yes | 2834 (58.4) | 2131 (75.2) | 703 (24.8) | |
| No | 2021 (41.6) | 1787 (88.4) | 234 (11.6) | |
| Hypertension, n (%) | < 0.01 | |||
| Yes | 2561 (52.7) | 2008 (78.4) | 553 (21.6) | |
| No | 2294 (17.3) | 1910 (83.3) | 384 (16.7) | |
| Diabetes, n (%) | 0.81 | |||
| Yes | 602 (12.4) | 488 (81.1) | 114 (18.9) | |
| No | 4253 (87.6) | 3430 (80.6) | 823 (19.4) | |
| TC (mmol/L), (SD) | 4.66 ± 0.99 | 4.62 ± 0.97 | 4.83 ± 1.08 | < 0.01 |
| HDL-C (mmol/L), (SD) | 1.29 ± 0.36 | 1.32 ± 0.35 | 1.17 ± 0.34 | < 0.01 |
| LDL-C (mmol/L), (SD) | 2.84 ± 0.91 | 2.83 ± 0.88 | 2.90 ± 1.00 | < 0.01 |
| TG (mmol/L), (SD) | 1.70 ± 1.66 | 1.58 ± 1.25 | 2.18 ± 1.86 | < 0.01 |
| Dyslipidemia, n (%) | < 0.01 | |||
| Yes | 1623 (33.4) | 1156 (29.5) | 467 (49.8) | |
| No | 3323 (66.6) | 2762 (70.5) | 470 (50.2) | |